Conference Coverage
Conference Coverage
Autoimmune disease linked to better late-stage breast cancer survival
Retrospective data hint at antitumor activity, but other explanations are possible
Conference Coverage
Breast cancer deaths take a big dip because of new medicines
Research model suggests a 58% overall mortality decline in 2019 from metastatic breast cancer.
Conference Coverage
Pseudocirrhosis in breast cancer may signal liver metastases
A better understanding of this common comorbidity could lead to better management and treatment.
Conference Coverage
Excess weight may ward off infection in breast cancer treatment
The study demonstrated significantly less frequent and less severe neutropenia in overweight and obese patients.
Conference Coverage
Women with HER2+ metastatic breast cancer are living longer
Overall survival improved 5.6% each year among over 5,000 patients in the study.
Conference Coverage
Treating bone loss ups survival for breast cancer patients
Findings suggest a trend toward reduction in contralateral breast cancer in the treatment group.
Conference Coverage
Pembrolizumab before surgery improves survival in early triple negative breast cancer
Treatment shifts residual cancer burden to lower categories.
Conference Coverage
New treatment outperforms chemo in HER2-low breast cancer
The results may cause clinicians to reconsider how they define HER2 expression in breast cancer.
Conference Coverage
New treatment meets unmet need in breast cancer
Expert calls advance incremental, but clinically important for women with HR positive/HER2 negative breast cancer.
Conference Coverage
ctDNA spots breast cancer recurrence
Personalized surveillance technique has the potential to augment adjuvant therapy and improve long-term outcomes.